Camela E, Villani A, Ocampo Garza SS, Costa C, Fabbrocini G, Megna M, et al. Development of a Patient-Reported Outcome Measure (PROM) for Dysgeusia During Treatment With Smoothened (SMO) Inhibitors for Basal Cell Carcinomas: The SMO-iD Questionnaire. Dermatol Pract Concept [Internet]. 2023 Jul. 31 [cited 2026 Apr. 22];13(3):e2023177. Available from: https://dpcj.org/index.php/dpc/article/view/2887